New experimental drugs could improve on Zepbound and Wegovy

A new wave of weight-loss therapies aims to be better than today’s GLP-1s

Pharmaceutical companies are developing experimental drugs that could potentially offer advantages over existing GLP-1 medications like Zepbound and Wegovy. These new drugs aim to address common side effects such as nausea and reduce the burden of daily pill-taking. The experimental treatments are being positioned as improvements to current weight loss and diabetes management options available on the market.